GC Genome Corporation (KOSDAQ:340450)

Revenue by Product

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cancer Test	10.20B
Cancer Test Growth	-2.52%
Obstetrics and Gynecology	6.53B
Obstetrics and Gynecology Growth	23.84%
Rare Genetic Disease	4.89B
Rare Genetic Disease Growth	-19.00%
Checkup	4.26B
Checkup Growth	-8.34%
Other	24.00M
Other Growth	-97.30%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
South Korea	25.12B
South Korea Growth	-2.37%
Overseas	767.00M
Overseas Growth	-50.86%